Internal Medicine, Infectious Disease · Phoenix, AZ
NPI
1750596789
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 W Thomas Rd Ste 900b
Phoenix, AZ, 85013
Phone (602) 406-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
480 services
Medicare patients, 2024
125
Average age 70
Drug cost, 2024
$1.5M
613 prescriptions
Company payments, 2025
$622
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mirella M Mircescu was code 99233 (hospital e&m - subsequent), 280 times for 67 patients. In total Mirella M Mircescu billed 480 services in 15 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 280 | 67 | $91.31 | $26K |
| 99223 Hospital E&M - Initial | Facility | 60 | 58 | $129.53 | $7,772 |
| 99214 Office E&M - Established | Office | 39 | 25 | $95.85 | $3,738 |
| 99204 Office E&M - New | Office | 22 | 22 | $123.36 | $2,714 |
| 99232 Hospital E&M - Subsequent | Facility | 14 | 12 | $60.36 | $845 |
| 90677 Vaccine Product | Office | 12 | 12 | $287.49 | $3,450 |
| G0009 Administration of pneumococcal vaccine | Office | 12 | 12 | $31.38 | $377 |
By year: 2022 $41K for 469 services; 2023 $50K for 512 services; 2024 $48K for 480 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mirella M Mircescu prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 102 prescriptions and refills. In total Mirella M Mircescu wrote 613 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 102 | 110 | 13 | $462K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 70 | 70 | Under 11 | $269K |
| Posaconazole Generic | 53 | 55 | Under 11 | $105K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 38 | 38 | Under 11 | $152K |
| Darunavir Generic | 33 | 33 | Under 11 | $34K |
| Tigecycline Generic | 28 | 28 | Under 11 | $14K |
| Ampicillin Sodium Generic | 18 | 18 | Under 11 | $1,941 |
| Vancomycin Hcl Generic | 16 | 16 | Under 11 | $1,781 |
| Cresemba Isavuconazonium Sulfate | 16 | 16 | Under 11 | $101K |
| Arikayce Amikacin Liposomal/Neb.Accessr | 16 | 16 | Under 11 | $231K |
| Ceftriaxone Ceftriaxone Sodium | 15 | 15 | Under 11 | $1,798 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 15 | 15 | Under 11 | $538 |
| Tivicay Dolutegravir Sodium | 14 | 20 | Under 11 | $47K |
| Cephalexin Generic | 14 | 39 | Under 11 | $651 |
| Rifabutin Generic | 12 | 16 | Under 11 | $6,619 |
Brand drugs: 288 claims; generic drugs: 325 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mirella M Mircescu $622 ($622 in general payments such as food, travel and fees) from 5 companies. The largest payer was Shionogi Inc with $230.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.